Fate Therapeutics Inc’s recent filing unveils that its Former Officer and Director Wolchko J Scott acquired Company’s shares for reported $0.1 million on Mar 06 ’25. In the deal valued at $0.93 per share,113,178 shares were bought.
Then, Bressi Jerome Charles sold 5,980 shares, generating $9,269 in total proceeds. Upon selling the shares at $1.55, the insider now owns 270,203 shares.
Before that, TAHL CINDY sold 5,654 shares. Fate Therapeutics Inc shares valued at $8,764 were divested by the insider at a price of $1.55 per share. As a result of the transaction, TAHL CINDY now holds 336,707 shares, worth roughly $0.25 million.
BofA Securities upgraded its Fate Therapeutics Inc [FATE] rating to a Neutral from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid June from “a Neutral” to “an Overweight”. H.C. Wainwright revised its rating on January 24, 2023. It rated FATE as “a Neutral” which previously was an “a Buy”.
Price Performance Review of FATE
On Friday, Fate Therapeutics Inc [NASDAQ:FATE] saw its stock jump 10.72% to $0.75. Over the last five days, the stock has lost -11.35%. Fate Therapeutics Inc shares have fallen nearly -54.37% since the year began. Nevertheless, the stocks have fallen -89.26% over the past one year. While a 52-week high of $7.34 was reached on 01/06/25, a 52-week low of $0.68 was recorded on 04/04/25. SMA at 50 days reached $1.1151, while 200 days put it at $2.5744.
Levels Of Support And Resistance For FATE Stock
The 24-hour chart illustrates a support level at 0.6878, which if violated will result in even more drops to 0.6226. On the upside, there is a resistance level at 0.7914. A further resistance level may holdings at 0.8298. The Relative Strength Index (RSI) on the 14-day chart is 36.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1125, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.55%. Stochastics %K at 14.95% indicates the stock is a buying.
How much short interest is there in Fate Therapeutics Inc?
A steep rise in short interest was recorded in Fate Therapeutics Inc stocks on 2025-03-14, growing by 1.51 million shares to a total of 14.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 13.06 million shares. There was a rise of 10.36%, which implies that there is a positive sentiment for the stock.
